VION Biosciences is a best-in-class life science platform delivering market-leading manufacturing and mission-critical chemicals and specialty reagents alongside value-added services to enable scientific discovery, clinical testing, therapeutic development, and innovative solutions.
Industry: Specialty Industrials
Sponsor: Iron Path Capital
Emergence Health (Urgent Care)
Formed by the merger of ClearChoiceMD and CareWell Urgent Care, Emergence Health is a provider of traditional and pediatric urgent care services, as well as in-house ancillary services including x-ray, lab services, pharmacy, and medication assisted treatment.
Industry: Healthcare Services
Sponsor: Iron Path Capital
*The specific Iron Path portfolio companies identified are not representative of the portfolio of a single investment vehicle managed by Iron Path, and it should not be assumed that an investment in such portfolio companies was or will be profitable. Actual holdings of any particular Iron Path investment vehicle will vary, and there is no guarantee that a particular vehicle will hold any of the portfolio companies listed (and no single vehicle shall hold all such companies).
†These investments (the “Pre-IPC Investments”) are portfolio companies of private investment funds advised by other private equity sponsors (inclusive of their affiliates, the “Prior Firms”), at which one or both of Iron Path’s Managing Partners (i.e., Reistetter and Mraz) previously performed investment activities, are used with the permission of such Prior Firm, and do not constitute “track record” information of Iron Path or any Managing Partner for purposes of the U.S. Investment Advisers Act of 1940, as amended. An investment in any fund sponsored by Iron Path does not represent an interest in any Pre-IPC Investment or any other portfolio company of private investment funds sponsored by the Prior Firms. Such Pre-IPC Investments are presented solely to illustrate the investment strategies which were used by the applicable Managing Partner while at such Prior Firm. No claim is made as to the performance of the Pre-ICP Investments by Iron Path, nor that its Managing Partners (or Iron Path itself) were in any way solely or primarily responsible for acquiring, holding, or exiting such Pre-IPC Investments. Other investment professionals (aside from the Managing Partners) at the Prior Firms participated in the investment process regarding such Pre-IPC Investments, including with respect to sourcing, negotiating, monitoring, and realizing such investments. Final investment decisions concerning the Pre-IPC Investments were made by investment committees of the applicable Prior Firm. No Prior Firm or its affiliates will be involved in investment management decisions regarding Iron Path’s funds and/or portfolio companies.